that FR940405-1-00140 25 138 197 234 246 266 275 370 466 473 492 536 561 611 619 647 675 700 720 740 772 789 806 828 852 870
a FR940405-1-00140 11 139 144 163 374 412 470 552 632 709 807 871
low FR940405-1-00140 1 140
spf FR940405-1-00140 4 141 165 176 554
product FR940405-1-00140 7 142 166 177 320 335 357 571
with FR940405-1-00140 3 143 787 835
flat FR940405-1-00140 1 145
absorbance FR940405-1-00140 1 146
spectrum FR940405-1-00140 6 147 190 229 291 364 600
could FR940405-1-00140 1 148
get FR940405-1-00140 2 149 168
four FR940405-1-00140 1 150
`` FR940405-1-00140 7 151 170 199 236 251 499 511
stars FR940405-1-00140 2 152 171
'' FR940405-1-00140 7 153 172 201 238 253 502 513
( FR940405-1-00140 12 154 285 289 303 523 527 601 636 703 744 794 841
ie FR940405-1-00140 1 155
, FR940405-1-00140 12 156 161 185 262 329 355 516 518 593 765 784 885
the FR940405-1-00140 54 157 174 188 194 198 208 218 222 227 231 235 247 250 267 276 279 312 316 356 367 388 434 437 463 478 484 493 498 542 546 576 579 585 597 612 623 644 672 680 686 697 724 737 741 752 758 763 769 779 822 832 849 855 862
highest FR940405-1-00140 1 158
rating FR940405-1-00140 1 159
) FR940405-1-00140 12 160 287 292 307 526 531 606 642 707 748 798 847
while FR940405-1-00140 1 162
higher FR940405-1-00140 3 164 175 181
would FR940405-1-00140 4 167 178 678 721
fewer FR940405-1-00140 1 169
because FR940405-1-00140 3 173 652 756
absorb FR940405-1-00140 1 179
disproportionately FR940405-1-00140 1 180
levels FR940405-1-00140 1 182
of FR940405-1-00140 28 183 211 226 249 283 300 315 331 343 376 390 398 406 414 421 436 508 578 588 625 689 733 757 778 781 831 854 864
uvb FR940405-1-00140 2 184 715
similar FR940405-1-00140 1 186
to FR940405-1-00140 17 187 207 216 242 351 417 442 475 490 551 569 590 603 682 685 692 730
action FR940405-1-00140 1 189
for FR940405-1-00140 1 191
erythema FR940405-1-00140 1 192
. FR940405-1-00140 35 193 230 271 305 308 326 366 378 401 425 448 456 462 483 529 532 545 556 575 607 638 643 671 696 705 736 746 768 802 821 843 848 866 883 899
comment FR940405-1-00140 9 195 232 273 368 464 485 804 823 850
stated FR940405-1-00140 4 196 674 739 869
star FR940405-1-00140 3 200 237 252
concept FR940405-1-00140 2 202 210
is FR940405-1-00140 3 203 240 581
in FR940405-1-00140 13 204 221 255 445 541 584 616 762 811 836 857 873 887
direct FR940405-1-00140 1 205
contrast FR940405-1-00140 1 206
accepted FR940405-1-00140 2 209 429
formulating FR940405-1-00140 1 212
sunscreen FR940405-1-00140 7 213 318 334 407 440 580 838
drug FR940405-1-00140 3 214 319 408
products FR940405-1-00140 4 215 409 509 783
provide FR940405-1-00140 1 217
most FR940405-1-00140 4 219 223 383 479
protection FR940405-1-00140 4 220 365 380 780
damaging FR940405-1-00140 1 224
portion FR940405-1-00140 1 225
uv FR940405-1-00140 4 228 344 379 391
contended FR940405-1-00140 4 233 369 535 646
method FR940405-1-00140 12 239 254 294 310 372 468 495 544 702 743 814 878
misleading FR940405-1-00140 1 241
consumers FR940405-1-00140 1 243
and FR940405-1-00140 11 244 323 505 521 563 640 659 728 809 845 894
added FR940405-1-00140 3 245 465 771
use FR940405-1-00140 2 248 654
england FR940405-1-00140 1 256
has FR940405-1-00140 4 257 373 410 815
been FR940405-1-00140 2 258 817
criticized FR940405-1-00140 1 259
by FR940405-1-00140 3 260 386 714
dermatologists FR940405-1-00140 1 261
who FR940405-1-00140 1 263
have FR940405-1-00140 2 264 559
asked FR940405-1-00140 1 265
system FR940405-1-00140 1 268
be FR940405-1-00140 5 269 359 683 881 892
withdrawn FR940405-1-00140 1 270
one FR940405-1-00140 3 272 701 803
recommended FR940405-1-00140 2 274 610
agency FR940405-1-00140 2 277 613
adopt FR940405-1-00140 2 278 615
current FR940405-1-00140 2 280 856
standards FR940405-1-00140 1 281
association FR940405-1-00140 1 282
australia FR940405-1-00140 1 284
sas FR940405-1-00140 3 286 494 543
uva FR940405-1-00140 15 288 301 399 422 481 488 514 599 626 656 662 734 754 767 876
broad FR940405-1-00140 2 290 363
test FR940405-1-00140 7 293 317 450 555 813 877 889
as2406 FR940405-1-00140 1 295
as FR940405-1-00140 3 296 361 796
an FR940405-1-00140 6 297 328 427 506 667 776
objective FR940405-1-00140 1 298
measure FR940405-1-00140 1 299
blocking FR940405-1-00140 3 302 389 423
ref FR940405-1-00140 4 304 528 704 745
17 FR940405-1-00140 2 306 530
this FR940405-1-00140 6 309 371 449 467 773 897
measures FR940405-1-00140 2 311 732
percent FR940405-1-00140 2 313 342
transmission FR940405-1-00140 2 314 624
between FR940405-1-00140 2 321 497
320 FR940405-1-00140 5 322 350 589 602 718
360 FR940405-1-00140 3 324 352 591
nm FR940405-1-00140 5 325 353 592 605 719
if FR940405-1-00140 1 327
layer FR940405-1-00140 1 330
appropriately FR940405-1-00140 3 332 384 668
dissolved FR940405-1-00140 1 333
does FR940405-1-00140 1 336
not FR940405-1-00140 5 337 549 567 614 816
transmit FR940405-1-00140 1 338
more FR940405-1-00140 1 339
than FR940405-1-00140 3 340 394 595
10 FR940405-1-00140 1 341
radiation FR940405-1-00140 3 345 627 657
at FR940405-1-00140 1 346
any FR940405-1-00140 1 347
wavelength FR940405-1-00140 2 348 792
from FR940405-1-00140 1 349
inclusive FR940405-1-00140 1 354
may FR940405-1-00140 1 358
considered FR940405-1-00140 1 360
providing FR940405-1-00140 1 362
number FR940405-1-00140 1 375
advantages FR940405-1-00140 1 377
claims FR940405-1-00140 1 381
are FR940405-1-00140 7 382 460 538 548 566 650 790
substantiated FR940405-1-00140 1 385
measuring FR940405-1-00140 3 387 395 622
directly FR940405-1-00140 1 392
rather FR940405-1-00140 2 393 594
some FR940405-1-00140 3 396 782 830
consequence FR940405-1-00140 1 397
exposure FR940405-1-00140 1 400
thin FR940405-1-00140 1 402
film FR940405-1-00140 1 403
spectrophotometric FR940405-1-00140 1 404
evaluation FR940405-1-00140 2 405 420
reached FR940405-1-00140 1 411
level FR940405-1-00140 1 413
technical FR940405-1-00140 1 415
proficiency FR940405-1-00140 1 416
permit FR940405-1-00140 1 418
instrumental FR940405-1-00140 1 419
potential FR940405-1-00140 1 424
adopting FR940405-1-00140 1 426
already FR940405-1-00140 1 428
standard FR940405-1-00140 2 430 898
protocol FR940405-1-00140 1 431
will FR940405-1-00140 2 432 451
enhance FR940405-1-00140 1 433
ability FR940405-1-00140 1 435
united FR940405-1-00140 1 438
states FR940405-1-00140 1 439
industry FR940405-1-00140 1 441
compete FR940405-1-00140 1 443
equally FR940405-1-00140 1 444
foreign FR940405-1-00140 1 446
markets FR940405-1-00140 1 447
substantially FR940405-1-00140 1 452
reduce FR940405-1-00140 1 453
testing FR940405-1-00140 2 454 839
costs FR940405-1-00140 1 455
no FR940405-1-00140 1 457
human FR940405-1-00140 2 458 875
subjects FR940405-1-00140 1 459
used FR940405-1-00140 1 461
provides FR940405-1-00140 1 469
strict FR940405-1-00140 1 471
criterion FR940405-1-00140 1 472
serves FR940405-1-00140 1 474
identify FR940405-1-00140 1 476
only FR940405-1-00140 2 477 583
effective FR940405-1-00140 3 480 501 801
blockers FR940405-1-00140 2 482 515
submitted FR940405-1-00140 2 486 824
several FR940405-1-00140 2 487 539
scans FR940405-1-00140 1 489
demonstrate FR940405-1-00140 1 491
differentiates FR940405-1-00140 1 496
poorly FR940405-1-00140 1 500
oxybenzonecontaining FR940405-1-00140 1 503
sunscreens FR940405-1-00140 2 504 865
assortment FR940405-1-00140 1 507
containing FR940405-1-00140 1 510
excellent FR940405-1-00140 1 512
eg FR940405-1-00140 1 517
titanium FR940405-1-00140 1 519
dioxide FR940405-1-00140 1 520
avobenzone FR940405-1-00140 2 522 797
parsol FR940405-1-00140 1 524
1789 FR940405-1-00140 1 525
two FR940405-1-00140 3 533 608 825
comments FR940405-1-00140 7 534 609 645 673 698 738 770
there FR940405-1-00140 1 537
deficiencies FR940405-1-00140 2 540 761
results FR940405-1-00140 3 547 681 750
correlated FR940405-1-00140 1 550
clinical FR940405-1-00140 1 553
numerous FR940405-1-00140 1 557
studies FR940405-1-00140 1 558
shown FR940405-1-00140 1 560
solution FR940405-1-00140 1 562
thinfilm FR940405-1-00140 1 564
spectra FR940405-1-00140 1 565
relevant FR940405-1-00140 1 568
actual FR940405-1-00140 2 570 687
performance FR940405-1-00140 2 572 577
on FR940405-1-00140 2 573 621
skin FR940405-1-00140 3 574 634 691
evaluated FR940405-1-00140 1 582
limited FR940405-1-00140 2 586 660
range FR940405-1-00140 2 587 661
throughout FR940405-1-00140 1 596
entire FR940405-1-00140 1 598
400 FR940405-1-00140 1 604
vitro FR940405-1-00140 5 617 812 837 858 888
methods FR940405-1-00140 4 618 649 859 890
rely FR940405-1-00140 1 620
through FR940405-1-00140 1 628
either FR940405-1-00140 1 629
epidermis FR940405-1-00140 1 630
or FR940405-1-00140 3 631 664 819
uvtransparent FR940405-1-00140 1 633
cast FR940405-1-00140 1 635
refs FR940405-1-00140 2 637 842
18 FR940405-1-00140 2 639 747
19 FR940405-1-00140 2 641 706
these FR940405-1-00140 2 648 676
inappropriate FR940405-1-00140 1 651
they FR940405-1-00140 1 653
nonsolar FR940405-1-00140 1 655
sources FR940405-1-00140 1 658
detectors FR940405-1-00140 2 663 665
without FR940405-1-00140 1 666
weighted FR940405-1-00140 1 669
response FR940405-1-00140 1 670
limitations FR940405-1-00140 1 677
cause FR940405-1-00140 1 679
nonrelevant FR940405-1-00140 1 684
responses FR940405-1-00140 1 688
normal FR940405-1-00140 1 690
fullspectrum FR940405-1-00140 1 693
natural FR940405-1-00140 1 694
sunlight FR940405-1-00140 1 695
mentioned FR940405-1-00140 1 699
contains FR940405-1-00140 1 708
small FR940405-1-00140 1 710
but FR940405-1-00140 1 711
significant FR940405-1-00140 1 712
contamination FR940405-1-00140 1 713
energy FR940405-1-00140 1 716
below FR940405-1-00140 1 717
adversely FR940405-1-00140 1 722
affect FR940405-1-00140 1 723
resulting FR940405-1-00140 1 725
efficacy FR940405-1-00140 2 726 735
values FR940405-1-00140 1 727
lead FR940405-1-00140 1 729
erroneous FR940405-1-00140 1 731
other FR940405-1-00140 1 742
skews FR940405-1-00140 1 749
toward FR940405-1-00140 1 751
longer FR940405-1-00140 1 753
wavelengths FR940405-1-00140 1 755
lamp FR940405-1-00140 1 759
's FR940405-1-00140 1 760
shorter FR940405-1-00140 1 764
energyrich FR940405-1-00140 1 766
skewing FR940405-1-00140 1 774
causes FR940405-1-00140 1 775
overestimation FR940405-1-00140 1 777
making FR940405-1-00140 1 785
those FR940405-1-00140 1 786
ingredients FR940405-1-00140 1 788
long FR940405-1-00140 1 791
absorbers FR940405-1-00140 1 793
such FR940405-1-00140 1 795
look FR940405-1-00140 1 799
unrealistically FR940405-1-00140 1 800
concluded FR940405-1-00140 1 805
rigorous FR940405-1-00140 1 808
foolproof FR940405-1-00140 1 810
established FR940405-1-00140 2 818 882
validated FR940405-1-00140 3 820 872 895
scientific FR940405-1-00140 1 826
publications FR940405-1-00140 1 827
discuss FR940405-1-00140 1 829
difficulties FR940405-1-00140 1 833
associated FR940405-1-00140 1 834
techniques FR940405-1-00140 1 840
15 FR940405-1-00140 1 844
20 FR940405-1-00140 1 846
argued FR940405-1-00140 1 851
none FR940405-1-00140 1 853
adequately FR940405-1-00140 1 860
evaluate FR940405-1-00140 1 861
photostability FR940405-1-00140 1 863
it FR940405-1-00140 1 867
further FR940405-1-00140 1 868
vivo FR940405-1-00140 1 874
must FR940405-1-00140 1 879
first FR940405-1-00140 1 880
then FR940405-1-00140 1 884
future FR940405-1-00140 1 886
can FR940405-1-00140 1 891
tested FR940405-1-00140 1 893
against FR940405-1-00140 1 896
several FR940405-1-00141 3 0 210 249
comments FR940405-1-00141 5 1 17 211 250 425
urged FR940405-1-00141 2 2 212
the FR940405-1-00141 63 3 16 35 39 48 64 69 74 77 82 92 108 165 169 190 213 217 230 243 258 269 298 307 331 347 351 368 373 380 394 405 424 441 455 469 477 481 491 496 501 506 510 537 553 560 567 572 582 601 619 626 666 699 721 725 752 810 816 825 838 857 868 876
agency FR940405-1-00141 2 4 214
not FR940405-1-00141 3 5 740 756
to FR940405-1-00141 14 6 88 132 177 200 215 330 341 364 523 579 614 730 866
adopt FR940405-1-00141 1 7
a FR940405-1-00141 23 8 19 97 113 146 237 252 313 327 339 390 412 463 486 514 528 660 702 736 762 783 798 889
testing FR940405-1-00141 13 9 27 93 143 219 246 299 464 483 561 637 713 887
method FR940405-1-00141 11 10 220 232 247 260 267 349 370 396 443 593
that FR940405-1-00141 16 11 141 168 193 229 264 271 285 290 325 427 480 550 585 724 813
utilizes FR940405-1-00141 1 12
photosensitizing FR940405-1-00141 5 13 40 142 183 194
chemicals FR940405-1-00141 1 14
. FR940405-1-00141 48 15 28 47 63 81 91 104 121 137 164 189 209 225 248 261 296 322 346 367 393 404 423 459 473 476 490 509 541 559 571 581 618 632 635 645 655 665 698 720 742 758 779 794 809 837 856 875 892
presented FR940405-1-00141 1 18
number FR940405-1-00141 5 20 147 253 487 503
of FR940405-1-00141 25 21 26 34 38 76 99 115 148 240 254 275 312 318 353 357 383 420 488 539 556 751 806 815 842 859
arguments FR940405-1-00141 1 22
against FR940405-1-00141 2 23 206
this FR940405-1-00141 4 24 265 543 592
type FR940405-1-00141 1 25
it FR940405-1-00141 3 29 279 447
is FR940405-1-00141 12 30 59 233 268 272 280 310 326 338 397 440 574
considered FR940405-1-00141 1 31
unethical FR940405-1-00141 1 32
because FR940405-1-00141 3 33 278 446
carcinogenic FR940405-1-00141 1 36
potential FR940405-1-00141 1 37
chemical FR940405-1-00141 2 41 71
( FR940405-1-00141 14 42 51 471 519 610 630 671 678 684 691 764 771 801 872
such FR940405-1-00141 2 43 151
as FR940405-1-00141 5 44 152 242 468 594
8mop FR940405-1-00141 6 45 55 105 122 180 305
) FR940405-1-00141 14 46 58 475 535 617 634 673 680 686 693 766 773 805 874
action FR940405-1-00141 4 49 187 430 517
spectrum FR940405-1-00141 9 50 75 316 343 450 458 518 544 604
ie FR940405-1-00141 4 52 520 611 802
, FR940405-1-00141 32 53 150 156 160 306 336 360 399 401 438 504 521 526 605 612 674 677 681 683 687 689 704 734 745 770 776 788 791 803 823 851 884
for FR940405-1-00141 11 54 127 130 204 221 256 287 432 596 743 833
induced FR940405-1-00141 1 56
erythema FR940405-1-00141 2 57 324
artificial FR940405-1-00141 1 60
and FR940405-1-00141 13 61 73 111 161 402 642 651 659 690 748 775 790 824
inappropriate FR940405-1-00141 1 62
values FR940405-1-00141 3 65 83 549
obtained FR940405-1-00141 3 66 84 827
vary FR940405-1-00141 1 67
with FR940405-1-00141 10 68 185 304 417 527 576 647 708 769 787
sensitizing FR940405-1-00141 1 70
used FR940405-1-00141 7 72 80 654 701 761 782 797
irradiating FR940405-1-00141 1 78
source FR940405-1-00141 1 79
have FR940405-1-00141 2 85 145
no FR940405-1-00141 1 86
relevance FR940405-1-00141 1 87
reallife FR940405-1-00141 1 89
situations FR940405-1-00141 1 90
may FR940405-1-00141 1 94
result FR940405-1-00141 1 95
in FR940405-1-00141 5 96 282 411 546 888
persistence FR940405-1-00141 1 98
pigmentation FR940405-1-00141 1 100
or FR940405-1-00141 2 101 181
blistering FR940405-1-00141 1 102
reactions FR940405-1-00141 5 103 120 129 208 289
sensitization FR940405-1-00141 1 106
exaggerates FR940405-1-00141 1 107
biological FR940405-1-00141 2 109 288
response FR940405-1-00141 6 110 317 328 340 511 562
presents FR940405-1-00141 1 112
risk FR940405-1-00141 4 114 126 366 578
causing FR940405-1-00141 1 116
severe FR940405-1-00141 1 117
ulcerative FR940405-1-00141 1 118
acute FR940405-1-00141 1 119
puts FR940405-1-00141 1 123
subjects FR940405-1-00141 6 124 363 580 644 646 710
at FR940405-1-00141 3 125 531 711
phototoxic FR940405-1-00141 2 128 207
up FR940405-1-00141 1 131
6 FR940405-1-00141 1 133
hours FR940405-1-00141 1 134
after FR940405-1-00141 2 135 881
exposure FR940405-1-00141 2 136 883
one FR940405-1-00141 6 138 226 270 460 780 795
comment FR940405-1-00141 10 139 166 191 227 461 478 583 620 722 811
contended FR940405-1-00141 1 140
methods FR940405-1-00141 3 144 174 196
benefits FR940405-1-00141 2 149 255
short FR940405-1-00141 1 153
irradiance FR940405-1-00141 2 154 569
times FR940405-1-00141 1 155
clearly FR940405-1-00141 1 157
defined FR940405-1-00141 1 158
endpoints FR940405-1-00141 1 159
reproducible FR940405-1-00141 2 162 403
results FR940405-1-00141 5 163 170 545 624 826
added FR940405-1-00141 2 167 584
from FR940405-1-00141 2 171 625
these FR940405-1-00141 3 172 829 860
test FR940405-1-00141 12 173 195 266 309 407 573 589 623 628 718 733 753
are FR940405-1-00141 3 175 436 821
relevant FR940405-1-00141 1 176
patients FR940405-1-00141 1 178
taking FR940405-1-00141 1 179
other FR940405-1-00141 1 182
drugs FR940405-1-00141 1 184
similar FR940405-1-00141 2 186 729
spectra FR940405-1-00141 2 188 431
concluded FR940405-1-00141 2 192 426
could FR940405-1-00141 1 197
be FR940405-1-00141 2 198 409
useful FR940405-1-00141 1 199
determine FR940405-1-00141 1 201
photoprotection FR940405-1-00141 1 202
factors FR940405-1-00141 1 203
claims FR940405-1-00141 1 205
accept FR940405-1-00141 1 216
ipd FR940405-1-00141 13 218 231 259 308 337 348 369 395 406 439 467 839 877
determining FR940405-1-00141 2 222 597
uva FR940405-1-00141 16 223 245 334 344 386 434 451 457 547 598 603 609 746 819 843 869
protection FR940405-1-00141 6 224 452 493 548 599 870
stated FR940405-1-00141 3 228 479 723
generally FR940405-1-00141 1 234
recognized FR940405-1-00141 1 235
by FR940405-1-00141 3 236 377 389
substantial FR940405-1-00141 1 238
body FR940405-1-00141 1 239
scientists FR940405-1-00141 1 241
preferred FR940405-1-00141 1 244
provided FR940405-1-00141 1 251
using FR940405-1-00141 5 257 301 466 542 828
they FR940405-1-00141 1 262
claimed FR940405-1-00141 1 263
most FR940405-1-00141 1 273
representative FR940405-1-00141 1 274
true FR940405-1-00141 2 276 314
conditions FR940405-1-00141 1 277
an FR940405-1-00141 3 281 586 731
vivo FR940405-1-00141 1 283
determination FR940405-1-00141 1 284
accounts FR940405-1-00141 1 286
can FR940405-1-00141 2 291 408
occur FR940405-1-00141 1 292
on FR940405-1-00141 3 293 848 853
living FR940405-1-00141 1 294
skin FR940405-1-00141 6 295 302 321 648 850 855
unlike FR940405-1-00141 2 297 323
procedure FR940405-1-00141 2 300 484
photosensitized FR940405-1-00141 1 303
indicative FR940405-1-00141 1 311
broad FR940405-1-00141 3 315 342 449
normal FR940405-1-00141 1 319
healthy FR940405-1-00141 1 320
only FR940405-1-00141 2 329 836
shorter FR940405-1-00141 1 332
wavelength FR940405-1-00141 2 333 608
radiation FR940405-1-00141 6 335 345 358 387 557 844
requires FR940405-1-00141 1 350
use FR940405-1-00141 1 352
considerably FR940405-1-00141 1 354
lower FR940405-1-00141 1 355
doses FR940405-1-00141 2 356 862
energy FR940405-1-00141 1 359
thus FR940405-1-00141 1 361
exposing FR940405-1-00141 1 362
less FR940405-1-00141 1 365
uniquely FR940405-1-00141 1 371
compliments FR940405-1-00141 1 372
current FR940405-1-00141 1 374
spf FR940405-1-00141 3 375 507 732
system FR940405-1-00141 1 376
accurately FR940405-1-00141 1 378
reflecting FR940405-1-00141 1 379
actual FR940405-1-00141 2 381 554
amount FR940405-1-00141 2 382 555
long FR940405-1-00141 2 384 607
wave FR940405-1-00141 1 385
attenuated FR940405-1-00141 1 388
sunscreen FR940405-1-00141 5 391 414 502 657 667
product FR940405-1-00141 1 392
reliable FR940405-1-00141 1 398
accurate FR940405-1-00141 1 400
performed FR940405-1-00141 1 410
standard FR940405-1-00141 1 413
evaluation FR940405-1-00141 1 415
laboratory FR940405-1-00141 1 416
minimal FR940405-1-00141 2 418 577
adaptation FR940405-1-00141 1 419
existing FR940405-1-00141 1 421
equipment FR940405-1-00141 1 422
until FR940405-1-00141 1 428
wellestablished FR940405-1-00141 1 429
specific FR940405-1-00141 1 433
damage FR940405-1-00141 1 435
established FR940405-1-00141 1 437
best FR940405-1-00141 1 442
currently FR940405-1-00141 1 444
available FR940405-1-00141 1 445
reflects FR940405-1-00141 1 448
equally FR940405-1-00141 1 453
across FR940405-1-00141 1 454
entire FR940405-1-00141 2 456 602
submitted FR940405-1-00141 3 462 621 741
protocol FR940405-1-00141 3 465 700 738
endpoint FR940405-1-00141 1 470
ref FR940405-1-00141 2 472 631
21 FR940405-1-00141 2 474 633
suggested FR940405-1-00141 1 482
fulfilled FR940405-1-00141 1 485
criteria FR940405-1-00141 1 489
resulting FR940405-1-00141 1 492
factor FR940405-1-00141 2 494 871
gives FR940405-1-00141 1 495
consumer FR940405-1-00141 1 497
additional FR940405-1-00141 1 498
information FR940405-1-00141 2 499 834
about FR940405-1-00141 1 500
complementing FR940405-1-00141 1 505
value FR940405-1-00141 1 508
variable FR940405-1-00141 1 512
has FR940405-1-00141 2 513 590
relatively FR940405-1-00141 1 515
flat FR940405-1-00141 1 516
320 FR940405-1-00141 1 522
400 FR940405-1-00141 2 524 615
nm FR940405-1-00141 3 525 534 616
low FR940405-1-00141 1 529
peak FR940405-1-00141 1 530
around FR940405-1-00141 1 532
340 FR940405-1-00141 2 533 613
throughout FR940405-1-00141 1 536
region FR940405-1-00141 1 538
interest FR940405-1-00141 1 540
closely FR940405-1-00141 1 551
reflect FR940405-1-00141 1 552
reduced FR940405-1-00141 1 558
obeys FR940405-1-00141 1 563
dose FR940405-1-00141 2 564 841
reciprocity FR940405-1-00141 1 565
over FR940405-1-00141 2 566 600
anticipated FR940405-1-00141 1 568
range FR940405-1-00141 1 570
practical FR940405-1-00141 1 575
eightcenter FR940405-1-00141 1 587
clinical FR940405-1-00141 2 588 622
validated FR940405-1-00141 1 591
acceptable FR940405-1-00141 1 595
including FR940405-1-00141 1 606
eight FR940405-1-00141 1 627
sites FR940405-1-00141 2 629 760
each FR940405-1-00141 2 636 712
facility FR940405-1-00141 1 638
completed FR940405-1-00141 1 639
between FR940405-1-00141 1 640
10 FR940405-1-00141 1 641
20 FR940405-1-00141 1 643
types FR940405-1-00141 1 649
iii FR940405-1-00141 1 650
iv FR940405-1-00141 1 652
were FR940405-1-00141 5 653 663 727 755 831
four FR940405-1-00141 1 656
formulations FR940405-1-00141 1 658
vehicle FR940405-1-00141 1 661
control FR940405-1-00141 1 662
tested FR940405-1-00141 1 664
products FR940405-1-00141 1 668
contained FR940405-1-00141 1 669
: FR940405-1-00141 1 670
1 FR940405-1-00141 1 672
padimate FR940405-1-00141 1 675
o FR940405-1-00141 1 676
2 FR940405-1-00141 1 679
oxybenzone FR940405-1-00141 2 682 688
3 FR940405-1-00141 1 685
4 FR940405-1-00141 2 692 694
percent FR940405-1-00141 1 695
titanium FR940405-1-00141 1 696
dioxide FR940405-1-00141 1 697
randomized FR940405-1-00141 1 703
complete FR940405-1-00141 2 705 886
block FR940405-1-00141 1 706
design FR940405-1-00141 1 707
all FR940405-1-00141 2 709 716
center FR940405-1-00141 1 714
receiving FR940405-1-00141 1 715
five FR940405-1-00141 1 717
materials FR940405-1-00141 1 719
studies FR940405-1-00141 1 726
conducted FR940405-1-00141 1 728
but FR940405-1-00141 1 735
detailed FR940405-1-00141 1 737
was FR940405-1-00141 4 739 845 863 878
example FR940405-1-00141 1 744
dosages FR940405-1-00141 1 747
application FR940405-1-00141 1 749
density FR940405-1-00141 1 750
sunscreens FR940405-1-00141 1 754
noted FR940405-1-00141 2 757 812
six FR940405-1-00141 1 759
150watt FR940405-1-00141 1 763
w FR940405-1-00141 1 765
xenon FR940405-1-00141 2 767 785
lamp FR940405-1-00141 3 768 786 800
mm FR940405-1-00141 1 772
wg335 FR940405-1-00141 2 774 789
ug11 FR940405-1-00141 2 777 792
filters FR940405-1-00141 2 778 793
site FR940405-1-00141 2 781 796
1000w FR940405-1-00141 1 784
krypton FR940405-1-00141 1 799
dermlite FR940405-1-00141 1 804
unspecified FR940405-1-00141 1 807
wattage FR940405-1-00141 1 808
neither FR940405-1-00141 1 814
last FR940405-1-00141 1 817
two FR940405-1-00141 2 818 861
sources FR940405-1-00141 1 820
recommended FR940405-1-00141 1 822
lamps FR940405-1-00141 1 830
included FR940405-1-00141 1 832
purposes FR940405-1-00141 1 835
threshold FR940405-1-00141 1 840
first FR940405-1-00141 1 846
measured FR940405-1-00141 1 847
unprotected FR940405-1-00141 1 849
then FR940405-1-00141 2 852 864
protected FR940405-1-00141 1 854
ratio FR940405-1-00141 1 858
calculated FR940405-1-00141 1 865
derive FR940405-1-00141 1 867
uvapf FR940405-1-00141 1 873
graded FR940405-1-00141 1 879
immediately FR940405-1-00141 1 880
uv FR940405-1-00141 1 882
allowing FR940405-1-00141 1 885
single FR940405-1-00141 1 890
visit FR940405-1-00141 1 891
the FR940405-1-00142 74 0 10 14 20 30 40 48 61 66 74 88 101 105 108 117 122 128 132 140 156 185 189 192 200 252 274 285 308 320 325 334 341 350 370 418 434 438 444 448 455 473 491 503 516 536 542 550 553 562 566 575 581 595 598 602 640 643 664 673 676 680 708 717 727 733 742 767 782 786 806 814 824 828 832
comment FR940405-1-00142 12 1 102 133 157 186 559 599 644 661 690 709 825
stated FR940405-1-00142 5 2 134 560 662 710
that FR940405-1-00142 20 3 9 92 104 114 135 139 148 188 421 476 561 601 646 663 692 701 711 816 827
comparison FR940405-1-00142 1 4
of FR940405-1-00142 22 5 13 107 127 163 260 284 297 310 327 352 447 454 490 521 530 552 594 675 697 719 803
test FR940405-1-00142 8 6 167 209 286 451 517 522 807
products FR940405-1-00142 4 7 64 147 288
indicated FR940405-1-00142 1 8
mean FR940405-1-00142 2 11 201
uvapf FR940405-1-00142 4 12 190 321 446
vehicle FR940405-1-00142 1 15
( FR940405-1-00142 10 16 25 34 44 53 215 225 266 344 373
1.7 FR940405-1-00142 1 17
) FR940405-1-00142 10 18 27 36 46 55 221 229 268 348 378
, FR940405-1-00142 41 19 21 28 31 41 49 75 87 112 170 241 243 244 246 248 273 358 364 381 384 387 412 414 426 431 464 469 519 524 528 532 588 591 620 622 654 656 670 672 741 785
padimate FR940405-1-00142 1 22
o FR940405-1-00142 1 23
product FR940405-1-00142 10 24 33 43 52 69 77 173 449 525 629
1.8 FR940405-1-00142 2 26 35
and FR940405-1-00142 20 29 47 168 219 247 304 386 415 465 497 509 571 619 635 657 726 756 764 771 797
oxybenzone FR940405-1-00142 3 32 42 76
were FR940405-1-00142 4 37 56 255 276
similar FR940405-1-00142 1 38
. FR940405-1-00142 40 39 65 78 100 131 155 184 202 217 222 227 251 269 281 294 319 340 346 389 417 433 452 472 486 512 534 545 557 597 642 659 688 707 737 751 766 780 805 823 842
2.1 FR940405-1-00142 1 45
titanium FR940405-1-00142 3 50 67 171
dioxide FR940405-1-00142 3 51 68 172
3 FR940405-1-00142 2 54 277
both FR940405-1-00142 1 57
significantly FR940405-1-00142 2 58 71
greater FR940405-1-00142 2 59 72
than FR940405-1-00142 2 60 73
other FR940405-1-00142 3 62 342 513
three FR940405-1-00142 2 63 203
was FR940405-1-00142 7 70 94 110 116 289 299 305
although FR940405-1-00142 1 79
overall FR940405-1-00142 1 80
statistical FR940405-1-00142 1 81
analysis FR940405-1-00142 1 82
detected FR940405-1-00142 1 83
significant FR940405-1-00142 1 84
sitebyproduct FR940405-1-00142 1 85
interaction FR940405-1-00142 2 86 98
individual FR940405-1-00142 1 89
results FR940405-1-00142 3 90 109 477
indicate FR940405-1-00142 2 91 138
this FR940405-1-00142 4 93 115 427 752
primarily FR940405-1-00142 1 95
a FR940405-1-00142 16 96 160 169 175 231 236 311 360 430 487 611 628 685 724 799 809
quantitative FR940405-1-00142 1 97
effect FR940405-1-00142 1 99
maintained FR940405-1-00142 2 103 826
consistency FR940405-1-00142 1 106
encouraging FR940405-1-00142 1 111
considering FR940405-1-00142 1 113
first FR940405-1-00142 1 118
experience FR940405-1-00142 1 119
in FR940405-1-00142 9 120 257 402 506 716 738 776 781 813
reading FR940405-1-00142 1 121
ipd FR940405-1-00142 13 123 141 208 329 336 493 554 567 603 634 647 665 706
response FR940405-1-00142 9 124 568 604 725 743 753 768 787 812
for FR940405-1-00142 8 125 459 541 565 578 586 616 831
most FR940405-1-00142 1 126
participating FR940405-1-00142 1 129
sites FR940405-1-00142 2 130 523
these FR940405-1-00142 2 136 712
data FR940405-1-00142 1 137
procedure FR940405-1-00142 1 142
can FR940405-1-00142 2 143 772
reliably FR940405-1-00142 1 144
discriminate FR940405-1-00142 1 145
among FR940405-1-00142 1 146
provide FR940405-1-00142 1 149
meaningful FR940405-1-00142 1 150
long FR940405-1-00142 1 151
wavelength FR940405-1-00142 1 152
uva FR940405-1-00142 5 153 371 391 699 804
protection FR940405-1-00142 4 154 332 339 700
proposed FR940405-1-00142 2 158 187
using FR940405-1-00142 2 159 206
base FR940405-1-00142 1 161
size FR940405-1-00142 2 162 520
20 FR940405-1-00142 1 164
subjects FR940405-1-00142 2 165 407
per FR940405-1-00142 3 166 263 292
as FR940405-1-00142 6 174 317 324 383 540 705
control FR940405-1-00142 1 176
to FR940405-1-00142 19 177 333 369 375 396 406 549 580 609 632 636 639 651 683 704 722 760 792 820
be FR940405-1-00142 6 178 191 610 652 761 774
run FR940405-1-00142 1 179
concurrently FR940405-1-00142 1 180
with FR940405-1-00142 9 181 235 240 314 331 365 379 408 422
each FR940405-1-00142 1 182
subject FR940405-1-00142 1 183
lower FR940405-1-00142 1 193
95 FR940405-1-00142 1 194
percent FR940405-1-00142 2 195 404
confidence FR940405-1-00142 1 196
interval FR940405-1-00142 1 197
subtracted FR940405-1-00142 1 198
from FR940405-1-00142 4 199 394 574 583
comments FR940405-1-00142 2 204 547
recommended FR940405-1-00142 1 205
an FR940405-1-00142 1 207
based FR940405-1-00142 1 210
upon FR940405-1-00142 2 211 679
two FR940405-1-00142 3 212 695 713
recent FR940405-1-00142 1 213
publications FR940405-1-00142 1 214
refs FR940405-1-00142 1 216
22 FR940405-1-00142 2 218 228
23 FR940405-1-00142 2 220 347
one FR940405-1-00142 4 223 558 689 739
study FR940405-1-00142 4 224 343 419 474
ref FR940405-1-00142 2 226 345
used FR940405-1-00142 1 230
xenon FR940405-1-00142 2 232 353
lamp FR940405-1-00142 1 233
equipped FR940405-1-00142 1 234
dichroic FR940405-1-00142 1 237
mirror FR940405-1-00142 1 238
filtered FR940405-1-00142 1 239
wg345 FR940405-1-00142 1 242
wg320 FR940405-1-00142 1 245
ug11 FR940405-1-00142 1 249
filters FR940405-1-00142 2 250 380
exposure FR940405-1-00142 5 253 303 471 750 796
increments FR940405-1-00142 4 254 259 275 405
programmed FR940405-1-00142 1 256
arithmetic FR940405-1-00142 1 258
2 FR940405-1-00142 5 261 290 467 484 791
joules FR940405-1-00142 1 262
square FR940405-1-00142 1 264
centimeter FR940405-1-00142 1 265
j/cm2 FR940405-1-00142 3 267 280 399
on FR940405-1-00142 4 270 307 437 495
protected FR940405-1-00142 3 271 439 496
skin FR940405-1-00142 10 272 409 440 499 582 589 596 641 778 815
or FR940405-1-00142 5 278 354 359 592 613
4 FR940405-1-00142 3 279 395 793
application FR940405-1-00142 2 282 526
density FR940405-1-00142 2 283 527
sunscreen FR940405-1-00142 1 287
milligrams FR940405-1-00142 1 291
cm2 FR940405-1-00142 1 293
visual FR940405-1-00142 1 295
assessment FR940405-1-00142 1 296
pigmentation FR940405-1-00142 2 298 313
done FR940405-1-00142 2 300 501
immediately FR940405-1-00142 1 301
after FR940405-1-00142 5 302 470 729 749 795
performed FR940405-1-00142 1 306
basis FR940405-1-00142 1 309
homogenous FR940405-1-00142 1 312
welldefined FR940405-1-00142 1 315
borders FR940405-1-00142 1 316
endpoints FR940405-1-00142 1 318
is FR940405-1-00142 10 322 428 500 569 624 735 744 754 769 788
determined FR940405-1-00142 2 323 839
ratio FR940405-1-00142 1 326
minimal FR940405-1-00142 3 328 335 492
dose FR940405-1-00142 4 330 337 687 802
without FR940405-1-00142 1 338
recommends FR940405-1-00142 1 349
use FR940405-1-00142 2 351 551
metal FR940405-1-00142 1 355
halide FR940405-1-00142 2 356 362
sources FR940405-1-00142 1 357
xenon/metal FR940405-1-00142 1 361
combination FR940405-1-00142 1 363
continuous FR940405-1-00142 1 366
spectra FR940405-1-00142 1 367
restricted FR940405-1-00142 1 368
spectrum FR940405-1-00142 4 372 564 577 830
320 FR940405-1-00142 1 374
390 FR940405-1-00142 1 376
nm FR940405-1-00142 1 377
such FR940405-1-00142 1 382
wg335 FR940405-1-00142 1 385
ug5 FR940405-1-00142 1 388
six FR940405-1-00142 1 390
doses FR940405-1-00142 3 392 435 494
ranging FR940405-1-00142 1 393
about FR940405-1-00142 1 397
30 FR940405-1-00142 1 398
are FR940405-1-00142 6 400 441 457 478 694 702
applied FR940405-1-00142 2 401 436
50 FR940405-1-00142 1 403
types FR940405-1-00142 2 410 779
ii FR940405-1-00142 1 411
iii FR940405-1-00142 1 413
iv FR940405-1-00142 1 416
states FR940405-1-00142 2 420 475
potential FR940405-1-00142 1 423
free FR940405-1-00142 1 424
interpolation FR940405-1-00142 1 425
actually FR940405-1-00142 1 429
progression FR940405-1-00142 1 432
multiplied FR940405-1-00142 1 442
by FR940405-1-00142 1 443
expected FR940405-1-00142 1 445
under FR940405-1-00142 1 450
observation FR940405-1-00142 1 453
responses FR940405-1-00142 1 456
delayed FR940405-1-00142 1 458
at FR940405-1-00142 6 460 483 502 731 746 790
least FR940405-1-00142 1 461
1 FR940405-1-00142 1 462
hour FR940405-1-00142 1 463
typically FR940405-1-00142 1 466
hours FR940405-1-00142 4 468 485 794 822
less FR940405-1-00142 1 479
variable FR940405-1-00142 3 480 655 763
if FR940405-1-00142 1 481
read FR940405-1-00142 4 482 736 745 789
simultaneous FR940405-1-00142 1 488
determination FR940405-1-00142 2 489 544
unprotected FR940405-1-00142 1 498
same FR940405-1-00142 2 504 537
time FR940405-1-00142 3 505 681 728
standard FR940405-1-00142 1 507
room FR940405-1-00142 1 508
illumination FR940405-1-00142 1 510
conditions FR940405-1-00142 1 511
parameters FR940405-1-00142 1 514
concerning FR940405-1-00142 1 515
area FR940405-1-00142 1 518
selection FR940405-1-00142 1 529
volunteers FR940405-1-00142 1 531
etc FR940405-1-00142 1 533
follow FR940405-1-00142 1 535
current FR940405-1-00142 1 538
standards FR940405-1-00142 1 539
spf FR940405-1-00142 1 543
several FR940405-1-00142 2 546 821
objected FR940405-1-00142 1 548
testing FR940405-1-00142 1 555
method FR940405-1-00142 3 556 740 784
action FR940405-1-00142 3 563 576 829
flat FR940405-1-00142 1 570
quite FR940405-1-00142 1 572
dissimilar FR940405-1-00142 1 573
damage FR940405-1-00142 3 579 618 638
ultraviolet FR940405-1-00142 1 584
light FR940405-1-00142 1 585
erythema FR940405-1-00142 1 587
cancer FR940405-1-00142 1 590
photoaging FR940405-1-00142 1 593
contended FR940405-1-00142 1 600
has FR940405-1-00142 4 605 648 757 836
not FR940405-1-00142 1 606
been FR940405-1-00142 4 607 649 758 837
demonstrated FR940405-1-00142 1 608
direct FR940405-1-00142 1 612
surrogate FR940405-1-00142 1 614
endpoint FR940405-1-00142 3 615 734 835
biological FR940405-1-00142 1 617
therefore FR940405-1-00142 1 621
there FR940405-1-00142 2 623 693
no FR940405-1-00142 1 625
relationship FR940405-1-00142 1 626
between FR940405-1-00142 1 627
's FR940405-1-00142 1 630
ability FR940405-1-00142 1 631
prevent FR940405-1-00142 2 633 637
added FR940405-1-00142 1 645
shown FR940405-1-00142 2 650 759
unstable FR940405-1-00142 1 653
nonlinear FR940405-1-00142 1 658
another FR940405-1-00142 1 660
reaction FR940405-1-00142 2 666 677
shows FR940405-1-00142 1 667
nonreciprocal FR940405-1-00142 1 668
behavior FR940405-1-00142 1 669
ie FR940405-1-00142 1 671
severity FR940405-1-00142 1 674
depends FR940405-1-00142 1 678
taken FR940405-1-00142 1 682
deliver FR940405-1-00142 1 684
certain FR940405-1-00142 1 686
noted FR940405-1-00142 1 691
methods FR940405-1-00142 2 696 714
assessing FR940405-1-00142 1 698
referred FR940405-1-00142 1 703
differ FR940405-1-00142 1 715
amount FR940405-1-00142 1 718
energy FR940405-1-00142 1 720
needed FR940405-1-00142 1 721
produce FR940405-1-00142 1 723
irradiation FR940405-1-00142 1 730
which FR940405-1-00142 1 732
45 FR940405-1-00142 1 747
seconds FR940405-1-00142 1 748
transient FR940405-1-00142 1 755
highly FR940405-1-00142 1 762
nonreproducible FR940405-1-00142 1 765
oxygendependent FR940405-1-00142 1 770
only FR940405-1-00142 1 773
elicited FR940405-1-00142 1 775
darker FR940405-1-00142 1 777
second FR940405-1-00142 1 783
uses FR940405-1-00142 1 798
much FR940405-1-00142 1 800
higher FR940405-1-00142 1 801
causes FR940405-1-00142 1 808
persistent FR940405-1-00142 2 810 833
pigment FR940405-1-00142 2 811 834
may FR940405-1-00142 1 817
last FR940405-1-00142 1 818
up FR940405-1-00142 1 819
neither FR940405-1-00142 1 838
nor FR940405-1-00142 1 840
published FR940405-1-00142 1 841
the FR940405-1-00143 4 0 4 18 26
comment FR940405-1-00143 2 1 27
argued FR940405-1-00143 1 2
that FR940405-1-00143 2 3 29
threshold FR940405-1-00143 1 5
problem FR940405-1-00143 1 6
of FR940405-1-00143 2 7 37
not FR940405-1-00143 2 8 43
having FR940405-1-00143 1 9
a FR940405-1-00143 1 10
truly FR940405-1-00143 1 11
solar FR940405-1-00143 1 12
uvaonly FR940405-1-00143 1 13
light FR940405-1-00143 1 14
source FR940405-1-00143 1 15
further FR940405-1-00143 1 16
complicates FR940405-1-00143 1 17
results FR940405-1-00143 1 19
obtained FR940405-1-00143 1 20
using FR940405-1-00143 1 21
either FR940405-1-00143 1 22
ipd FR940405-1-00143 1 23
method FR940405-1-00143 1 24
. FR940405-1-00143 1 25
contended FR940405-1-00143 1 28
even FR940405-1-00143 1 30
filtered FR940405-1-00143 1 31
xenon FR940405-1-00143 1 32
lamps FR940405-1-00143 1 33
contain FR940405-1-00143 1 34
significant FR940405-1-00143 1 35
amounts FR940405-1-00143 1 36
visible FR940405-1-00143 1 38
radiation FR940405-1-00143 1 39
which FR940405-1-00143 1 40
, FR940405-1-00143 1 41
while FR940405-1-00143 1 42
harmful FR940405-1-00143 1 44
